ACUTA CAPITAL PARTNERS, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001582844

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2024 · 41 positions · Total reported value $123.46M · Top-10 concentration 61.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 52.9% · 11 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.5% · Prev Value $143.49M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -8.3% · vs SPY -10.5% · Latest Value $126.75M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, ACUTA CAPITAL PARTNERS, LLC disclosed 41 equity positions with a combined reported value of $123.46M. The filing implies a focused portfolio: its ten largest positions account for 61.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were PCVX ($15.47M), OCUL ($10.35M), TRML ($8.54M). By sector, the heaviest allocations are Health Care 74.6%, Other 25.4%. Versus the prior quarter, allocation shifted toward Other (+9.0pp) and away from Health Care (-9.0pp).

Versus the prior quarter, ACUTA CAPITAL PARTNERS, LLC opened 11 new positions, trimmed 7 and fully exited 0, a turnover rate of 52.9% of positions. The portfolio's overlap with the prior quarter was 51% of names.

The largest new positions opened in Q3 2024 were ASND ($3.14M), CMPS ($2.43M), SLRN ($1.79M).

Of the 8 positions fully exited versus the prior quarter, the largest were SRPT ($4.34M), AGIO ($3.39M), VRDN ($2.59M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • ASND ASCENDIS PHARMA A/S · $3.14M
  • CMPS COMPASS PATHWAYS PLC · $2.43M
  • SLRN ACELYRIN INC · $1.79M
  • EWTX EDGEWISE THERAPEUTICS INC · $1.68M
  • GILD GILEAD SCIENCES INC · $1.63M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · $1.39M
  • UNCY UNICYCIVE THERAPEUTICS INC · $807.32K
  • LQDA LIQUIDIA CORPORATION · $735.00K

Fully Exited (vs previous quarter)

  • SRPT SAREPTA THERAPEUTICS INC · prev qtr: $4.34M
  • AGIO AGIOS PHARMACEUTICALS INC · prev qtr: $3.39M
  • VRDN VIRIDIAN THERAPEUTICS INC · prev qtr: $2.59M
  • ORIC ORIC PHARMACEUTICALS INC · prev qtr: $678.72K · history
  • PLRX PLIANT THERAPEUTICS INC · prev qtr: $496.65K
  • NAMS NEWAMSTERDAM PHARMA COMPANY · prev qtr: $432.23K
  • CLRB CELLECTAR BIOSCIENCES INC · prev qtr: $176.25K
  • SVRA SAVARA INC · prev qtr: $100.75K

Insider Transactions (Form 4)

Latest ACUTA CAPITAL PARTNERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Acuta Capital Partners, based in Redwood City, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $143.49M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: REDWOOD CITY, CA, United States
  • SEC registration: 801-136966 (status: Approved), registered 2026-09-09
  • Regulatory AUM (Form ADV): $172.53M as of 2026-06-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: acutacapital.com

Portfolio Structure

  • 23 positions · $143.49M reported value (Q2 2026)
  • Top 10 holdings = 73.7% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 19.3%
  • Average position size: $6.24M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 7 added, 6 reduced, 7 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 74.6%
Other 25.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 135.40K $15.47M 12.53%
12.53%
Add
2 1.19M $10.35M 8.39%
8.39%
Reduce
3 332.10K $8.54M 6.92%
6.92%
Add
4 107.50K $7.85M 6.36%
6.36%
Add
5 296.37K $7.57M 6.13%
6.13%
Reduce
6 131.70K $6.73M 5.45%
5.45%
Reduce
7 62.10K $5.19M 4.20%
4.20%
Add
8 1.26M $5.18M 4.20%
4.20%
Add
9 108.00K $4.90M 3.97%
3.97%
Reduce
10 2.12M $4.26M 3.45%
3.45%
Reduce
11 487.00K $4.06M 3.29%
3.29%
Add
12 197.00K $3.85M 3.12%
3.12%
Add
13 1.85M $3.81M 3.09%
3.09%
Hold
14 190.00K $3.51M 2.84%
2.84%
Reduce
15 57.50K $3.31M 2.68%
2.68%
Reduce
16 5.90K $3.20M 2.59%
2.59%
Add
17 21.00K $3.14M 2.54%
2.54%
New
18 386.50K $2.43M 1.97%
1.97%
New
19 1.20M $2.27M 1.84%
1.84%
Reduce
20 180.94K $1.89M 1.53%
1.53%
Add
21 364.00K $1.79M 1.45%
1.45%
New
22 63.00K $1.68M 1.36%
1.36%
New
23 46.20K $1.66M 1.34%
1.34%
Reduce
24 19.50K $1.63M 1.32%
1.32%
New
25 25.10K $1.39M 1.13%
1.13%
New
26 290.50K $970.27K 0.79%
0.79%
Add
27 1.98M $807.32K 0.65%
0.65%
New
28 73.50K $735.00K 0.59%
0.59%
New
29 146.10K $707.12K 0.57%
0.57%
New
30 154.90K $703.25K 0.57%
0.57%
New
31 46.60K $694.81K 0.56%
0.56%
Add
32 44.00K $679.80K 0.55%
0.55%
New
33 13.70K $415.11K 0.34%
0.34%
New
34 18.50K $381.65K 0.31%
0.31%
Reduce
35 17.60K $360.45K 0.29%
0.29%
Reduce
36 120.50K $309.69K 0.25%
0.25%
Reduce
37 54.00K $274.86K 0.22%
0.22%
New
38 29.80K $273.86K 0.22%
0.22%
New
39 19.00K $265.81K 0.21%
0.21%
New
40 15.51K $210.13K 0.17%
0.17%
New
41 90.83K $8.89K 0.01%
0.01%
Hold

FAQ

What did ACUTA CAPITAL PARTNERS, LLC buy in 2024-Q3?

In its 2024-Q3 13F filing, ACUTA CAPITAL PARTNERS, LLC reported 41 equity positions worth $123.46M in aggregate; its largest disclosed positions were PCVX ($15.47M), OCUL ($10.35M), TRML ($8.54M).

How large is ACUTA CAPITAL PARTNERS, LLC's portfolio?

ACUTA CAPITAL PARTNERS, LLC reported $123.46M of long equity holdings across 41 positions as of 2024-Q3. Top-10 holdings account for 61.6% of reported value.

What is ACUTA CAPITAL PARTNERS, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/acuta-capital-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →